Expression and Significance of Insulin Receptor Substrate 1 in Human Hepatocellular Carcinoma
Table 1
Baseline characteristics of patients.
Variables
HCC
LC
CH
value
Total number,
100
20
20
Number of specimens,
200
20
20
HCC
100
Paracancerous tissues
100
Age, years
Mean age
0.427
≥55, (%)
55 (55.0)
8 (40.0)
8 (40.0)
0.276
<55, (%)
45 (45.0)
12 (60.0)
12 (60.0)
—
Sex
Male, (%)
69 (69.0)
13 (65.0)
10 (50.0)
0.262
Female, (%)
31 (31.0)
7 (35.0)
10 (50.0)
—
Hepatitis virus
HBsAg+, (%)
66 (66.0)
11 (55.0)
9 (45.0)
0.173
Anti-HCV+, (%)
7 (7.0)
1 (5.0)
1 (5.0)
0.909
Both HBV and HCV, (%)
2 (2.0)
0 (0.0)
0 (0.0)
—
None, (%)
25 (25.0)
8 (40.0)
10 (50.0)
0.054
Pathologic diagnosis
HCC, (%)
100 (100)
—
—
Cirrhosis, (%)
—
20 (100)
—
Chronic hepatitis, (%)
—
—
20 (100)
CH: chronic hepatitis; HCC: hepatocellular carcinoma; LC: liver cirrhosis Two hundred and forty specimens were drawn from 140 patients, including 100 HCC tissues and 100 paracancerous tissues from 100 HCC patients, 20 cirrhosis tissues from 20 LC patients, and 20 chronic hepatitis tissues from 20 CH patients.